Skip to content

The Effectiveness of Group Ending Self-Stigma in Patients with Psychogenic Non-Epileptic Seizures

The Effectiveness of Group Ending Self-Stigma (ESS) Intervention on Stigmaand Resilience in Patients with Psychogenic Non-Epileptic Seizures (PNES)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250630066311N1
Enrollment
28
Registered
2025-08-29
Start date
2025-08-23
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychogenic Non-Epileptic Seizures (PNES). Conversion disorder with seizures or convulsions

Interventions

Intervention group: 9 weekly group psychotherapy sessions with de-stigmatization content for patients with psychogenic non-epileptic seizure disorder ESS is a group intervention designed by clinical a

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Definitive diagnosis of PNES by a neurologist based on long-term video EEG (at least 24 hours) and standard clinical examinations confirmed 2. Age 18 to 60 years (due to developmental and therapeutic differences at younger ages and issues associated with aging) 3. Minimum diploma education (to understand and participate effectively in therapy sessions) 4. At least 6 months of medically confirmed history of PNES (to ensure diagnosis stability) Signing written informed consent

Exclusion criteria

Exclusion criteria: Concurrent diagnosis of epilepsy or other neurocognitive disorders (confirmed by a neurologist) 2. Presence of active psychotic or bipolar disorders (assessed by SCID-5) 3. Suicidal risk (score greater than 15 on the Beck Suicide Scale) 4. Substance abuse or dependence in the past 6 months, assessed by structured clinical interview(SCID) 5 Urine test for drugs at baseline Substance Abuse Screening Questionnaire (ASSIST)

Design outcomes

Primary

MeasureTime frame
1. Perceived stigma. Timepoint: Before intervention - after intervention - three months later. Method of measurement: (Measured with a stigma scale).

Secondary

MeasureTime frame
Quality of life. Timepoint: Before intervention - after intervention - three months later. Method of measurement: Assessment with the WHO-QOL questionnaire.;The level of anxiety. Timepoint: Before intervention - after intervention - three months later. Method of measurement: (Measured with BAI questionnaire).;Severity of depression. Timepoint: Before intervention - after intervention - three months later. Method of measurement: Assessment with BDI-II questionnaire).

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmahsa ghorbani

Mashhad University of Medical Sciences

ghorbanim4013@mums.ac.ir+98 51 3848 9162

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026